Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. (Q51888707)

17 April 2018

title

Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. (English)

1 reference

17 April 2018

0 references

1 reference

L A Ouimet

1

1 reference

17 April 2018

A Stewart

2

1 reference

17 April 2018

B Collins

3

1 reference

17 April 2018

D Schindler

4

1 reference

17 April 2018

C Bielajew

5

1 reference

17 April 2018

publication date

3 June 2008

1 reference

17 April 2018

Neuropsychology, Development and Cognition. Section A: Journal of Clinical and Experimental Neuropsychology

published in

1 reference

17 April 2018

volume

31

1 reference

17 April 2018

issue

1

1 reference

17 April 2018

page(s)

73-89

1 reference

17 April 2018

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Breast cancer treatment and cognitive functioning: current status and future challenges in assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Reliable change scores and their relation to perceived change in memory: implications for the diagnosis of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Assessing clinically relevant cognitive decline: preliminary data on a new method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Cognitive heterogeneity in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Verbal memory outcome in patients with normal preoperative verbal memory and left mesial temporal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Determining empirically based self-reported cognitive change: development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Determining reliable cognitive change after epilepsy surgery: development of reliable change indices and standardized regression-based change norms for the WMS-III and WAIS-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Standard regression-based methods for measuring recovery after sport-related concussion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

The Use of Current Reading Ability in the Assessment of Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Assessment of statistical change criteria used to define significant change in neuropsychological test performance following cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

A method for assessing clinically relevant individual cognitive change in older adult populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Mild cognitive impairment: conceptual issues and structural and functional brain correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

The effects of hormone therapy on cognition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Neuropsychology of chronic fatigue syndrome: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

Assessing cognitive function in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

'Chemobrain' in breast carcinoma?: a prologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13803390801992725

10.1080/13803390801992725

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

18608651

1 reference

17 April 2018